Glycated haemoglobin
Biomarker2 papers
- Human trial1
Latest
24Diabetes/metabolism Research and ReviewsHumans
Abdominal MRI-Derived Liver, Visceral Fat, and Pancreatic Phenotypes Improve Prediction of Incident Type 2 Diabetes
LancetHuman trial
Orforglipron matches insulin glargine on cardiovascular safety
Over a median two years, major adverse cardiovascular events occurred in 4.2% of orforglipron participants compared with 5.0% of insulin glargine…Over a median two years, major adverse cardiovascular events occurred in 4.2% of orforglipron participants compared with 5.0% of insulin glargine controls.
LancetHuman trial
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Bodyweight fell by up to 18.8% with weekly retatrutide compared with 5.1% on placebo at week 80 in adults with obesity and type 2 diabetes.Bodyweight fell by up to 18.8% with weekly retatrutide compared with 5.1% on placebo at week 80 in adults with obesity and type 2 diabetes.
European Heart JournalHuman trial
Potential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetes
European Heart JournalHuman trial